» Articles » PMID: 35833151

A Comparative Modeling Study of Thermal Mitigation Strategies in Irreversible Electroporation Treatments

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Irreversible electroporation (IRE), also referred to as nonthermal pulsed field ablation (PFA), is an attractive focal ablation modality for solid tumors and cardiac tissue due to its ability to destroy aberrant cells with limited disruption of the underlying tissue architecture. Despite its nonthermal cell death mechanism, application of electrical energy results in Joule heating that, if ignored, can cause undesired thermal injury. Engineered thermal mitigation (TM) technologies including phase change materials (PCMs) and active cooling (AC) have been reported and tested as a potential means to limit thermal damage. However, several variables affect TM performance including the pulsing paradigm, electrode geometry, PCM composition, and chosen active cooling parameters, meaning direct comparisons between approaches are lacking. In this study, we developed a computational model of conventional bipolar and monopolar probes with solid, PCM-filled, or actively cooled cores to simulate clinical IRE treatments in pancreatic tissue. This approach reveals that probes with integrated PCM cores can be tuned to drastically limit thermal damage compared to existing solid probes. Furthermore, actively cooled probes provide additional control over thermal effects within the probe vicinity and can altogether abrogate thermal damage. In practice, such differences in performance must be weighed against the increased time, expense, and effort required for modified probes compared to existing solid probes.

Citing Articles

Thermal side effects during pulsed field ablation: an analysis using computer modelling.

Mercado-Montoya M, Gomez-Bustamante T, Mickelsen S, Kulstad E, Gonzalez-Suarez A, Overzet L Europace. 2025; 27(3).

PMID: 39960855 PMC: 11879925. DOI: 10.1093/europace/euaf035.


Investigation of High Frequency Irreversible Electroporation for Canine Spontaneous Primary Lung Tumor Ablation.

Hay A, Aycock K, Lorenzo M, David K, Coutermarsh-Ott S, Salameh Z Biomedicines. 2024; 12(9).

PMID: 39335552 PMC: 11428908. DOI: 10.3390/biomedicines12092038.


Cardiac blood vessels and irreversible electroporation: findings from pulsed field ablation.

Chinyere I, Mori S, Hutchinson M Vessel Plus. 2024; 8.

PMID: 38646143 PMC: 11027649. DOI: 10.20517/2574-1209.2023.80.


Opportunities and Challenges in Catheter-Based Irreversible Electroporation for Ventricular Tachycardia.

Repp M, Chinyere I Pathophysiology. 2024; 31(1):32-43.

PMID: 38251047 PMC: 10801500. DOI: 10.3390/pathophysiology31010003.


Recent Advancements in Electroporation Technologies: From Bench to Clinic.

Campelo S, Huang P, Buie C, Davalos R Annu Rev Biomed Eng. 2023; 25:77-100.

PMID: 36854260 PMC: 11633374. DOI: 10.1146/annurev-bioeng-110220-023800.


References
1.
Geboers B, Scheffer H, Graybill P, Ruarus A, Nieuwenhuizen S, Puijk R . High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy. Radiology. 2020; 295(2):254-272. DOI: 10.1148/radiol.2020192190. View

2.
Narayanan G, Hosein P, Arora G, Barbery K, Froud T, Livingstone A . Percutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinoma. J Vasc Interv Radiol. 2012; 23(12):1613-21. DOI: 10.1016/j.jvir.2012.09.012. View

3.
Checcucci E, Amparore D, De Luca S, Autorino R, Fiori C, Porpiglia F . Precision prostate cancer surgery: an overview of new technologies and techniques. Minerva Urol Nefrol. 2019; 71(5):487-501. DOI: 10.23736/S0393-2249.19.03365-4. View

4.
Li W, Fan Q, Ji Z, Qiu X, Li Z . The effects of irreversible electroporation (IRE) on nerves. PLoS One. 2011; 6(4):e18831. PMC: 3077412. DOI: 10.1371/journal.pone.0018831. View

5.
Davalos R, Mir I, Rubinsky B . Tissue ablation with irreversible electroporation. Ann Biomed Eng. 2005; 33(2):223-31. DOI: 10.1007/s10439-005-8981-8. View